(DUROLANE®) Hyaluronic Acid Stabilized Single Injection
Indication of Use
DUROLANE (3 mL): Symptomatic treatment of mild to moderate knee or hip osteoarthritis.
DUROLANE SJ (1 mL): Symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, and toes.
Both DUROLANE and DUROLANE SJ are also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure. There are no known contraindications
You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/or stiffness at the injection site.
Advantages
DUROLANE Hyaluronic acid is injected into the affected joint, providing pain relief that is proven to last up to 6 months.
DUROLANE Hyaluronic acid also may do more than relieve osteoarthritis pain longer: a 2015 clinical study has shown that hyaluronic acid treatments can substantially delay the need for knee replacement surgery. Findings also show a further delay in knee replacement surgery with each additional course of treatment.
DUROLANE has been approved in the EU for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.
